Donna Snyder, MD, MBE
Executive Physician, WCG
Biography
Donna Snyder, MD, MBE, is the executive physician at WCG providing guidance on medicine, research, and regulations. Before WCG, Dr. Snyder served as senior pediatric ethicist, in the Office of Pediatric Therapeutics, at the Food and Drug Administration (FDA). She is a board-certified pediatrician with experience in pediatric practice and research ethics.
Latest insights by Donna
WCG Clinical | Insights
6 Ethical Considerations for Clinical Research Involving AI: What Sponsors and CROs Need to Know
Blog Posts
WCG Clinical | Insights
Framework for Review of Clinical Research Involving AI: Advancing Ethical Oversight in Clinical Research
Blog Posts
WCG Clinical | Insights
Health Literacy in Action: The Impact of Plain Language Communication in Clinical Research
Podcasts
WCG Clinical | Insights
FDA Guidance on AI-Enabled Devices: Transparency, Bias, & Lifecycle Oversight
Blog Posts
WCG Clinical | Insights
Pioneering Ethical Oversight in AI-Enabled Clinical Research: Insights on the New Framework
Blog Posts
WCG Clinical | Insights
Review of the FDA Draft Guidance: Considerations for Including Tissue Biopsies in Clinical Trials
Blog Posts
WCG Clinical | Insights
The Role of AI in Regulatory Decision-Making for Drugs & Biologics: the FDA’s Latest Guidance
Blog Posts
WCG Clinical | Insights
The FDA Accepts ICH E11A on Pediatric Extrapolation: How Does This Impact Your Pediatric Study?
Blog Posts
WCG Clinical | Insights
FDA’s Single IRB Requirement, Expected but Not Guaranteed in 2025
Blog Posts
WCG Clinical | Insights